Sangamo Therapeutics said the Food and Drug Administration has cleared its investigational new drug application for its ST-400 treatment for intractable pain due to idiopathic small fiber neuropathy.

This page is a valuable resource, featuring a complete guide to the latest medications-both generic and branded-ideal for relieving Peripheral Neuropathy symptom. Learn about various drugs ...

It seems that further studies on the exact mechanism of the action of this drug would be worth while. In the form of Altafur, Eaton Laboratories, Norwich, New York. In the form of Chloromycetin ...

A dedicated FAQ section is available for common drugs to address questions and provide a deeper understanding of Diabetic Neuropathy management options. Remember to consult your healthcare ...

Mexiletine has been evaluated in several randomised, placebo-controlled trials in patients with painful diabetic neuropathy. The drug decreased mean visual analogue scale (VAS) pain ratings in all ...

A recent study from the Federal University of São Paulo (UNIFESP) has found that using infrared light along with regular ...

a new study showed. The clinical trial, led by Wilmot Cancer Institute members Jennifer Gewandter, Ph.D., MPH, and Nimish Mohile, MD, MS, is the first randomized placebo-controlled study to test daily ...

The U.S. Food and Drug Administration has put on hold a trial of Novavax's COVID-influenza and its standalone flu vaccines after a participant who took the combination shot reported nerve damage, the ...